From reactive denial management to upstream prevention
Denials are usually discovered after adjudication. The revenue loss, however, often begins much earlier.
Hospitals continue to invest significant time and resources in denial management, yet roughly 15% of claims are initially denied. Hospitals spend nearly $19.7 billion each year appealing them and only about half of those denials are ultimately overturned.
That raises a more useful question than how quickly a team can work a denial after it occurs: Where did the risk enter the revenue cycle in the first place?
For many organizations, the answer is somewhere upstream.
The financial risk starts upstream
A registration error that looks minor at intake can create an eligibility problem later. An authorization that does not match the service delivered creates another point of exposure. Add documentation that lacks the specificity needed to support coding and a claim may already be compromised before anyone in billing sees it.
In 2025, 68% of revenue cycle leaders identified inaccurate or incomplete patient data at intake as a driver of denials.
The operational implication is significant. When information is not corrected where it enters the workflow, the work does not disappear. It moves downstream.
Staff may spend time researching payer requirements, correcting account information, rebuilding claims or preparing appeals for issues that could have been addressed much earlier. By then, several small gaps may have compounded into a much larger reimbursement problem.
Denial prevention changes where that work happens.
Reporting explains the past; intervention can change the claim.
Traditional denial analytics are good at telling leaders what has already gone wrong.
A monthly report can identify the payer generating the most denials, show where a denial category is increasing or reveal recurring root causes. The problem is timing. By the time the pattern appears on a dashboard, the affected claims have already gone to the payer.
That is one reason healthcare organizations are investing more heavily in technology that can bring intelligence into active workflows. Nearly half of healthcare executives identify the revenue cycle as their top area for IT investment, with growing attention to automation, artificial intelligence and predictive analytics.
Seeing a problem sooner only helps if someone can do something about it.
The opportunity is to move from retrospective visibility to in-flight intervention.
Earlier signals give teams more options
The sooner a potential denial surfaces, the more choices a team has for addressing it.
An eligibility discrepancy can be resolved during intake rather than after billing. Authorization mismatches can be flagged while the case is still active, when there is still time to reconcile the service and payer requirements. On the clinical side, documentation exceptions can be routed for review before they become coding or billing problems.
Claims can also be evaluated for denial risk before submission, helping staff identify which cases warrant closer review instead of applying the same level of effort across every account.
That does not remove professional judgment from the process. It gives staff better signals and gives them those signals at a point when intervention can still matter.
Payer intelligence is becoming more important as well. Requirements change. Documentation expectations vary, and actual payer behavior does not always mirror the written rule.
In a 2026 federal review of Medicare Advantage skilled nursing facility authorizations, 97% of appealed denials issued by one major authorization contractor were ultimately overturned.
For providers, that kind of finding underscores the need to understand how payer requirements play out in practice. Applying that intelligence inside the workflow can help teams identify exceptions earlier and focus attention where the reimbursement risk is highest.
A denial should leave the process better than it found it
Some denials are unavoidable. Repeating the same preventable denial is a different problem.
When a denial occurs, organizations should be able to trace it back to the workflow, decision or data element that contributed to it. If the same authorization issue continues to appear, the answer cannot be to simply get better at appealing it. The underlying process needs to change.
This is where denial data becomes more valuable.
Patterns can inform registration workflows, authorization controls, documentation practices, claim edits and staff education. Over time, the organization moves from repeatedly correcting downstream failures to strengthening the processes that created them.
The financial stakes are substantial. In 2025, final denials and uncompensated care contributed to a loss of more than $48 billion in net revenue across more than 2,300 hospitals, a 25% increase from the prior year.
Even a modest reduction in avoidable denials can reduce rework, support more predictable reimbursement and preserve staff capacity for the exceptions, escalations and decisions that genuinely require judgment.
Strong denial management will remain necessary. But it should not be the first line of defense.
For revenue cycle leaders, the larger opportunity is to identify risk closer to where it begins, apply payer requirements within the workflow and give teams the information they need before a preventable issue becomes a denied claim.
The goal is not simply to work denials faster. It is to create fewer reasons for a claim to be denied in the first place.